期刊文献+

宫颈癌组织HPV58的检测及其E7基因的克隆和表达 被引量:3

Detection of HPV 58 and cloning of its E7 gene in cervical cancer
原文传递
导出
摘要 目的 检测宫颈癌组织中人乳头瘤病毒 5 8型 (HPV5 8)并克隆表达其E7基因。方法采用GP5 +/GP6 +引物系统扩增 5 8例宫颈癌组织 ,将荧光偏振 (FP)检测技术与模板指导的末端延伸反应 (TDI FP)结合 ,检测HPV5 8,确定HPV5 8感染阳性宫颈癌组织。用特异引物从HPV5 8阳性标本中扩增HPV5 8早期表达蛋白E7基因 ,将其连入pGEM TEasy载体 ,获得克隆重组体HPV5 8E7 pGEM T ,并测序验证。将E7基因与pRSET A融合表达载体连接 ,获得E7表达重组体pRSET 5 8E7,转化大肠杆菌BL2 1(DE3) ,并用IPTG诱导表达。结果  5 8例宫颈癌标本中 ,HPV5 8阳性 10例 ,占 5 2例HPV阳性标本的 19.2 %。从其中扩增到了HPV5 8E7基因并构建了其克隆和表达重组体。其表达重组体经IPTG诱导后 ,可表达Mr16× 10 3 的HPV5 8E7His6融合蛋白 ,表达量占菌体蛋白的 30 %。结论 欧美国家少见的高危HPV5 8在中国陕西人宫颈癌组织中并不少见。HPV5 8E7重组表达体可在大肠杆菌中高效表达 ,为HPV5 Objective To detect HPV 58, a common type of human papillomavirus (HPV), clone and express its E7 gene from biopsy specimens of cervical cancer. Methods HPV 58 from 58 biopsy tissues of cervical cancer was detected by GP5+/GP6+ PCR followed by template-directed dye-terminator incorporation assay with fluorescence polarization detection (TDI-FP). HPV 58 E7 gene was amplified from one HPV 58-positive sample, and then cloned into pGEM-T Easy vector. The recombinant plasmid, HPV58E7-pGEM-T was confirmed by sequencing. Subsequently, E7 gene was cloned into prokaryotic expression vector pRSET-A. The constructed pRSET-58E7 plasmids were transfected into BL21(DE3)cells, and induced to express 58 E7 protein by IPTG. Results Among the 58 biopsy tissues of cervical cancer, 10 were HPV 58-positive, accounting for 19.2% of 52 HPV-positive cases. HPV 58 E7 gene was amplified from one HPV 58-positive sample. The constructed plasmids were identified containing HPV58 E7 gene by restriction enzyme analysis and sequencing. SDS-PAGE analysis showed that HPV58 E7 His6 fusion protein of M_r16×10~3 was expressed by pRSET-58E7 after induction by IPTG. The fusion protein accounted for 30% of total bacterial proteins. Conclusion HPV 58 is not uncommon in Chinese women with cervical cancer in Shaanxi province. Constructed HPV58 E7 recombinant plasmids can be effectively expressed in E.coli, which may provide a tool in diagnosis and vaccine design for HPV of HPV58-associated tumors.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2004年第9期543-546,共4页 Chinese Journal of Oncology
关键词 HPV E7基因 宫颈癌组织 克隆和表达 阳性标本 扩增 重组体 克隆表达 高效表达 诱导表达 Human papillomavirus type 58 E7 gene Gene cloning Fluorescence polarization Cervical neoplasms
  • 相关文献

参考文献11

  • 1Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev, 2003,16:1-17.
  • 2Bosch FX, Manos MM, Munoz N,et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer, 1995, 87: 796-802.
  • 3Liaw KL, Hsing AW, Chen CJ, et al. Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer, 1995,62:565-571.
  • 4Huang S, Afonina I, Miller BA, et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer, 1997,70:408-411.
  • 5Chan PK, Li WH, Chan MY, et al. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions. J Med Virol, 1999,59:232-238.
  • 6de Roda Husman AM, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol, 1995,76:1057-1062.
  • 7van den Brule AJ, Pol R, Fransen-Daalmeijer N, et al. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol, 2002,40:779-787.
  • 8Kirii Y, Iwamoto S, Matsukura T. Human papillomavirus type 58 DNA sequence. Virology, 1991,185:424-427.
  • 9Michel N, Osen W, Gissmann L, et al. Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. Virology, 2002,294:47-59.
  • 10Meschede W, Zumbach K, Braspenning J, et al. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol, 1998,36:475-480.

二级参考文献8

  • 1魏军,张正.人乳头瘤病毒PCR产物酶标-微孔板杂交分型[J].中华检验医学杂志,1998,22(3):41-43. 被引量:7
  • 2Jastreboff AM, Cymet T. Role of the human papilloma virus in the development of cervical intraepithelial neoplasis and malignancy.Postgrad Med J, 2002,78:225-228.
  • 3Kulasingam SL, Hughes JP, Kiviat NB, et 81. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities:comparison of sensitivity, specificity, and frequency of referral. JAMA,2002, 288: 1749-1757.
  • 4Wright JD, Herzog TJ. Human papillomavirus: emerging trends in detection and management. Current Womens Health Rep, 2002,2: 259-265.
  • 5Castle PE, Lorincz AT, Mielzynska-Lohnas I, et al. Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible. J Clin Microbiol, 2002.40:1088-1090.
  • 6Hsu TM, Chen X, Duan S, et al. Universal SNP genotyping assay with fluorescence polarization detection. Biotechniques, 2001,31:560-568.
  • 7汪江华,府伟灵,王颖莹,朱前勇.组合靶基因自动检测仪快速检测人乳头瘤病毒[J].中华检验医学杂志,2000,23(5):264-266. 被引量:18
  • 8董学君,张国荣,王少波,徐国强,叶飞,胡若愚.性传播人乳头瘤病毒16型调查及L1区片段的序列分析[J].中华检验医学杂志,2000,23(5):282-282. 被引量:4

共引文献11

同被引文献44

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部